首页> 外文OA文献 >Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report—Usage of Immune Checkpoint Inhibition in CMMRD

【2h】

Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report—Usage of Immune Checkpoint Inhibition in CMMRD

机译：免疫检查点抑制作用CMMRD患者IDH1-突变体的主要佐剂治疗：一种案例报告 - 在CMMRD中免疫检查点抑制的情况

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rebekah Rittberg; Craig Harlos; Heidi Rothenmund; Anirban Das; Uri Tabori; Namita Sinha; Harminder Singh; Bernie Chodirker; Christina A. Kim;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Maximizing response: a case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma [J] . Greally Megan, Agarwal Rajiv, Dika Imane El, Journal of Gastrointestinal Oncology . 2019,第2期

机译：最大化反应：先前有化学难治性转移性食管癌患者免疫检查点抑制后抢救化疗的一例报道
2. Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination [J] . Wouter W. van Willigen, Martine Bloemendal, Marye J. Boers-Sonderen, Oncoimmunology. . 2020,第1期

机译：辅助疾病治疗辅助树突细胞疫苗接种反复性疾病治疗的转移性黑色瘤患者的反应及存活
3. CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy [J] . Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, Journal for ImmunoTherapy of Cancer . 2020,第2期

机译：CDK4 / 6抑制抑制在临床前模型中提高化疗和免疫检查点抑制剂组合的抗肿瘤功效，增强了SCLC接受化疗的患者T细胞活化
4. Polymeric nanoparticles improve antibody delivery to tumors and tumor draining lymph nodes to enhance cancer immunotherapy via checkpoint inhibition [C] . David M. Francis, Alex Schudel, Nathan A. Rohner, Society for Biomaterials annual meeting and exposition . 2019

机译：聚合纳米颗粒改善了抗体向肿瘤和引流淋巴结的递送，从而通过检查点抑制增强了癌症免疫疗法
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an [O] . Rebekah Rittberg, Craig Harlos, Heidi Rothenmund, 2021

机译：免疫检查点抑制作是初级佐剂治疗
7. CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy [O] . Anne Y Lai, Jessica A Sorrentino, Konstantin H Dragnev, 2020

机译：CDK4 / 6抑制抑制在临床前模型中提高化疗和免疫检查点抑制剂组合的抗肿瘤功效，增强了SCLC接受化疗的患者T细胞活化
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report—Usage of Immune Checkpoint Inhibition in CMMRD

著录项

引文网络

相似文献

相关主题

期刊订阅